PerkinElmer Q3 Revenues Increase 3 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer's third quarter revenues increased 3 percent year over year, the firm reported after the close of the market on Wednesday.

For the three months ended Sept. 29, total revenues rose to $524.3 million from $509.6 million a year ago. Analysts, on average, expected revenues of $523.8 million.

On an organic basis, revenues rose 2 percent year over year, PerkinElmer Chairman and CEO Robert Friel said on a conference call following the release of the results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?